Maximize Your Impact At SynBioBeta 2026
SynBioBeta 2026, scheduled for May 4 at the San Jose Convention Center in California, unites the biggest thinkers and decision-makers in synthetic biology, biotechnology, and life sciences. The event draws executives from fast-growing startups, multinational pharma, bioengineering firms, VCs, and government institutions—all focused on scaling the next wave of bio-based innovation.
This is more than a showcase for breakthrough science; it’s a marketplace for strategic deals, partnerships, and pilot project approvals. Many attendees hold decision-making authority on technology procurement, R&D investments, and commercialization strategies. It’s a place where funding conversations move forward, platform alliances are considered, and demand generation opportunities take shape.
With Vendelux’s enriched attendee list, teams can tap into who’s attending ahead of time. You’ll gain visibility into active stakeholders in synthetic biology—from founding scientists to corporate innovation leads—giving you the information needed to craft intentional early outreach plans.
How Sales, Marketing and Revops Teams Can Use This Attendee List
This event is a unique touchpoint for teams selling into biotech, pharma, or life science sectors. Use Vendelux’s enriched conference attendee list to focus outreach on companies actively investing in synthetic biology and biomanufacturing innovation.
Segment your outreach based on industry, company stage, or technical focus—whether it’s platform companies, ingredient producers, or sustainability-driven startups. Customize outreach for decision-makers in innovation, partnerships, or procurement roles. The attendee data helps book meetings with funding leads, R&D chairs, and corporate development contacts who come to SynBioBeta with defined goals.
Teams can also use the data to shape on-site engagement strategies. Instead of waiting for booth traffic, your team can plan strategic meetings with the right people—then follow up using contact details and context from the attendee list. This is how to get more meetings, build relevance, and convert interest into multi-quarter relationships.
Timing Is Everything
SynBioBeta 2026 takes place on May 4, 2026. While the event itself spans just one day, many attendees plan their schedules well in advance to maximize meetings and deal flow.
Using Vendelux now, sales and marketing teams can begin outreach up to 11 months in advance by aligning campaign timing with active decision cycles in the synthetic biology sector. Gain an early edge by reaching out to verified conference attendees before they finalize their event calendars. This window is critical for starting high-value conversations with innovators and capital allocators who will be in San Jose.
What’s Included In The SynBioBeta 2026 Attendee List?
Vendelux provides visibility into executives expected to attend SynBioBeta 2026 through a combination of organizer-sourced data and proprietary predictive intelligence. Clients can also upload their target account lists to surface high-priority contacts who will be present.
The enriched list includes first and last names, job titles, company names, company websites, location details (city, state, and country), LinkedIn profiles, verified email addresses, and phone numbers when available. This detailed information enables structured, high-impact outreach grounded in verified attendee data.
Where Is SynBioBeta 2026?
The event will be held at the San Jose Convention Center in California, United States.
When Is SynBioBeta 2026?
SynBioBeta 2026 takes place on May 4, 2026.
What Type Of Event Is SynBioBeta 2026?
SynBioBeta 2026 is a leading industry conference focused on synthetic biology and bio-based innovation. The event includes keynotes from biotech leaders, technology showcases, expert panels, and curated networking sessions that connect scientists, entrepreneurs, and corporate partners.
How Many People Attend SynBioBeta 2026?
The event is expected to attract over 1,500 attendees from across North America and beyond, including a high concentration of founders, C-level executives, scientists, investors, and innovation leads shaping the future of synthetic biology.
